Next Article in Journal
Genome and Comparative Transcriptome Analysis of Growth and Developmental Changes in the Pileus of the Cyclocybe chaxingu
Previous Article in Journal
Advancing the Identification of Risk Factors for Invasive Fungal Disease in Children with Cancer
 
 
Search for Articles:
Title / Keyword
Author / Affiliation / Email
Journal
Article Type
 
 
Advanced Search
 
Section
Special Issue
Volume
Issue
Number
Page
 
Journals
JoF
Volume 12
Issue 1
10.3390/jof12010061
jof-logo
Submit to this Journal Review for this Journal Propose a Special Issue
► Article Menu

Article Menu

share Share announcement Help format_quote Cite question_answer Discuss in SciProfiles
first_page
settings
Order Article Reprints
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Review

Genetic Manipulation in Sporothrix Species: Molecular Tools, Challenges, and Applications

by
Mafalda Barros
1,2,
Matheus Tavares
1,2,
Ricardo Silvestre
1,2,
Roberta Peres da Silva
3,† and
Fernando Rodrigues
1,2,*,†
1
Life and Health Sciences Research Institute (ICVS), School of Medicine, University of Minho, 4710-057 Braga, Portugal
2
ICVS/3B’s-PT Government Associate Laboratory, 4806-909 Braga, Portugal
3
Department of Microbiology, Immunology and Parasitology, Paulista School of Medicine, Federal University of São Paulo (UNIFESP), São Paulo 04023-062, Brazil
*
Author to whom correspondence should be addressed.
†
These authors contributed equally to this work.
J. Fungi 2026, 12(1), 61; https://doi.org/10.3390/jof12010061
Submission received: 4 December 2025 / Revised: 7 January 2026 / Accepted: 10 January 2026 / Published: 13 January 2026
(This article belongs to the Special Issue Advances in Fungal Genetic Manipulation: From Conventional Systems to Historically Intractable Fungi)
Browse Figure
Review Reports Versions Notes

Abstract

Sporothrix species are thermally dimorphic fungi responsible for sporotrichosis, a globally prevalent subcutaneous mycosis and an emerging zoonotic threat, particularly in South America. The high virulence of Sporothrix brasiliensis and its efficient transmission from cats to humans have intensified recent outbreaks, underscoring the importance of understanding the pathogenic mechanisms. While several putative virulence factors have been identified, such as melanin production, cell wall remodeling, extracellular vesicles, and thermotolerance, functional studies remain hampered by limited molecular tools. Recent advances, including random mutagenesis, protoplast-mediated transformation, Agrobacterium tumefaciens-mediated transformation, RNA interference and CRISPR/Cas9-based genome editing, are changing this landscape. These methods have enabled the functional validation of key virulence factors and the investigation of gene function in both environmental and clinical strains. In this review, we summarize the genetic toolbox available for Sporothrix, outline current challenges, and discuss how these strategies are reshaping the study of fungal virulence and host–pathogen interactions.

1. Sporothrix Species and Sporotrichosis

Sporotrichosis is a subcutaneous disease caused by thermally dimorphic fungi of the genus Sporothrix, which are commonly found in soil and decaying organic matter [1,2]. Phylogenetic analyses have revealed that Sporothrix schenckii, historically considered the only etiological agent, represents a cryptic species complex comprising several clinically relevant species, namely S. schenckii sensu stricto, S. brasiliensis, S. globosa, and S. luriei [1,3], which form a distinct lineage from plant-associated Sporothrix species.
Thermal dimorphism represents a key virulence attribute in pathogenic Sporothrix species. Under environmental conditions (25 °C to 27 °C), the fungus grows as conidium-producing mycelia, whereas exposure to host physiological temperatures (35 °C to 37 °C) triggers the transition to the parasitic yeast phase. This transition is essential for establishing an infection and disseminating it to different tissues [2]. Despite sharing this conserved trait, each species exhibits different pathogenic potential, largely influenced by host–pathogen interactions and immune evasion strategies [4].
Pathogenic Sporothrix species differ in both transmission patterns and geographic distribution, reflecting ecological adaptation and virulence potential. S. schenckii, the primary agent of sporotrichosis in most endemic regions, is widely distributed worldwide and predominantly transmitted sapronotically from environmental sources, particularly in tropical and subtropical areas [2]. In contrast, S. brasiliensis is largely restricted to South America and has emerged as a highly virulent zoonotic pathogen. Domestic cats serve as efficient reservoirs and transmitters of the fungus to other animals and humans through scratches, bites, or contact with infected secretions. This shift from environmental to animal-associated transmission leads to more severe and atypical clinical manifestations, including extracutaneous disease, in both immunocompetent and immunocompromised hosts [5,6,7,8]. S. globosa predominates in parts of Asia, illustrating the species-specific geographic structuring of sporotrichosis. The emergence of S. brasiliensis highlights the link between transmission mode, epidemic potential, and pathogenic fitness.
Virulence factors are microbial components, including structural molecules and specialized strategies, that promote host colonization by facilitating adhesion, invasion, nutrient acquisition, immune evasion, and survival within host tissues. These factors are often dispensable for saprophytic growth but are essential for successful pathogenesis. In pathogenic fungi, virulence is best understood in the context of dynamic host–pathogen interactions, and advances in genomics, transcriptomics, and proteomics have enabled the identification of conserved and species-specific virulence determinants.
Among medically relevant fungi, canonical virulence traits of Sporothrix species include thermal dimorphism and thermotolerance, remodeling of the fungal cell wall, expression of heat shock proteins (HSPs), production of protective pigments such as melanin, secretion of hydrolytic enzymes, resistance to host-derived stresses, and the ability to form biofilms [9,10]. Although comprehensive reviews of Sporothrix virulence have been published elsewhere [9,11,12], the following section summarizes the principal factors identified to date and highlights how recent molecular approaches have enabled more in-depth functional characterization.

2. Virulence Factors and Sporothrix Species Pathogenicity

The mycelium-to-yeast transition of Sporothrix species is essential for pathogenicity. This morphological switch is known to be regulated by complex signaling pathways, including those involving calcium signaling and the DRK1 (Dimorphism-Regulating Kinase 1). In S. schenckii, calcium uptake stimulates the dimorphic transition by activating Ca2+/calmodulin-dependent protein kinases (CaMKs) via interaction with calmodulin (CaM). The kinase Sscmk1, a central CaMK in S. schenckii, is essential for both the yeast-to-mycelium switch and proper progression through the yeast cell cycle [13,14].
The fungal cell wall plays a key role in the virulence of Sporothrix species, mediating host adhesion, immune evasion, and infection. Its composition is dynamic and influenced by environmental conditions, such as growth media and nutrient availability, affecting cell wall architecture and virulence potential [15]. Nutrient availability modulates fungal metabolic pathways and influences cell wall remodeling, thereby contributing to differences in pathogenic potential. Consequently, inoculum preparation conditions in experimental infection models represent an important determinant of virulence. The inoculum of S. brasiliensis and S. schenckii prepared under carbon- or nitrogen-limited conditions displays reduced virulence due to remodeling in cell wall architecture and composition [16,17].
Villalobos-Duno et al. evaluated the composition of polysaccharides of the pathogenic yeast form of five Sporothrix strains, two of S. brasiliensis and three of S. schenckii, with differences in virulence profile [17]. They reported a higher chitin content in the cell wall of all S. brasiliensis strains tested when compared to the other Sporothrix species. Remarkably, these authors found a mathematical expression that establishes the positive relation between the cell wall rhamnose-to-β-glucan ratio with the virulence in Sporothrix species. Structural differences in the cell wall of rhamnomannan were also described, with longer side chains in less virulent strains, underscoring its role in Sporothrix species pathogenicity. Lozoya-Pérez et al. also reported the negative association between higher β-glucan exposure and virulence in S. brasiliensis, S. schenckii and S. globosa [16]. Although the cell wall proteome of Sporothrix species is poorly understood, several studies have identified adhesins, such as the 70 kDa glycoprotein (Gp70), that mediate binding to extracellular matrix (ECM) components like fibronectin and laminin [12,18,19]. Gp70 is present in S. brasiliensis, S. schenckii, and S. globosa [20,21], whose expression has been associated with virulence. This glycosylated cell wall protein plays a dual role in Sporothrix pathogenicity: it is essential for adhesion but also makes the fungus more visible to the immune system. High virulence strains are associated with Gp70 downregulation, suggesting that immune evasion through reduced expression of this surface antigen contributes to more severe or persistent infections [22]. Additionally, Pap1 (Peptidorhamnomannan-associated protein 1) plays a critical role in host–pathogen interaction by mediating adhesion to type I and II collagen, laminin, fibronectin, elastin, and fibrinogen of the ECM, facilitating fungal adherence to host tissues. Research using Galleria mellonella larvae revealed that challenges with Pap1 before infection protected animals from a lethal challenge of S. schenckii or with yeast pretreated with anti-Pap1 antibodies [23]. These data emphasize the immunogenic potential of Pap1. Sporothrix species cell wall polysaccharides and glycoproteins are also modified with N-linked and/or O-linked glycans. These modifications are now known to be functionally associated with fungal pathogenesis and host interaction, which, among others, seems to involve alterations in the exposure of chitin and β-glucans at the cell wall [23,24].
Melanin, a dark biopolymer integrated into the fungal cell wall, is a well-established virulence factor in Sporothrix species, where it plays key roles in environmental resilience, antifungal resistance, and immune evasion [25,26]. These fungi can synthesize at least three structurally distinct types of melanin—1,8-dihydroxynaphthalene (DHN)-melanin, eumelanin, and pyomelanin—through independent biosynthetic pathways [27]. Briefly, melanin is produced through the oxidative polymerization of phenolic compounds, becoming incorporated into the fungal cell wall, where it acts as a physical and chemical barrier against host antimicrobial mechanisms, namely reactive oxygen species (ROS) and nitric oxide (NO) [28,29]. Its presence also contributes to resistance against antifungal agents, such as terbinafine and amphotericin B, by reducing their accessibility to intracellular targets [26]. In vivo studies have demonstrated that melanin-deficient strains of S. schenckii markedly exhibit reduced virulence and impaired tissue invasion compared to wild-type (WT) strains [29]. In S. globosa, melanin has been shown to inhibit macrophage phagocytosis and suppress the host’s inflammatory response. Guan et al. found that melanin downregulates the production of pro-inflammatory cytokines, such as tumor necrosis factor alpha (TNF-α) and interleukin (IL)-6, suppresses ROS and NO synthesis, and reduces the expression of key components of the innate immune recognition system, including toll-like receptors (TLR) (e.g., TLR2 and TLR4) [30].
Fungal extracellular vesicles (EVs) are structures that facilitate intercellular communication and modulate host–pathogen interactions by transporting bioactive molecules, including proteins, lipids, polysaccharides, and nucleic acids. First described in Cryptococcus neoformans in 2007, EVs have been identified in several other fungal pathogens, including species of the Sporothrix complex [31,32]. In vitro and in vivo studies have highlighted the functional role of S. brasiliensis EVs in infection, demonstrating that they enhance fungal burden. In dendritic cells, these vesicles stimulate phagocytosis and increase fungal replication, while in macrophages, they upregulate MHC class II and CD86, elevate IL-6 and IL-12, and intensify fungicidal activity [33]. In vivo, mice pre-treated with high concentrations of EVs developed larger lesions and higher fungal loads, particularly at early stages of infection [34]. Comparative studies have revealed that S. brasiliensis produces EVs with a higher abundance of immunologically active components than S. schenckii, which can be associated with its higher pathogenic potential [33]. Proteomic analyses identified 63 proteins in EVs from S. brasiliensis, with 27% uncharacterized, and only 40 proteins in S. schenckii, of which 35% lacked functional annotation [9,34]. Most of the identified proteins are associated with stress responses, oxidation–reduction processes, and DNA metabolic activity, being essential for fungal survival under host-stress conditions. S. brasiliensis EVs carried immunogenic components, such as HSPs and cell wall-remodeling enzymes, while S. schenckii EVs were enriched in core metabolic enzymes, including glyceraldehyde-3-phosphate dehydrogenase, as well as transcription and translation factors. Only a few proteins were reported to be shared between the species, reflecting distinct virulence strategies and immune interactions. Taken together, these findings highlight EVs as critical modulators of fungal–host interactions in Sporothrix species and suggest that their unique molecular cargo, especially in S. brasiliensis, may contribute significantly to disease severity, immune evasion, and fungal persistence. Their emerging roles make them promising biomarkers and therapeutic targets in sporotrichosis.
Investigating the virulence factors of Sporothrix species is fundamental to elucidating the molecular mechanisms underlying sporotrichosis infection and disease progression. Characterizing these determinants of pathogenicity not only deepens our understanding of fungal–host interactions and the pathobiology of the disease but also guides the development of improved diagnostics, targeted antifungal therapies, and effective prevention and management strategies. Achieving these objectives depends critically on the continuous advancement and strategic application of molecular tools designed to study gene function and regulation in these dimorphic fungi. Genetic manipulation technologies have emerged as essential approaches for functionally validating putative virulence genes and dissecting their roles in pathogenesis. In the following section, we present the diverse genetic methodologies applied in Sporothrix species and how they enabled the experimental validation of key virulence factors, highlighting the impact of molecular genetics on our ability to interrogate pathogenic mechanisms at a functional level.

3. Molecular Tools for Genetic Manipulation in Sporothrix Species

Phenotypic differences in Sporothrix species may be linked to the expansion or contraction of specific gene families. Previous studies suggest that clinical species evolved from environmental species, with the four main clinical species (S. brasiliensis, S. schenckii, S. globosa, and S. luriei) exhibiting a high degree of endemicity [35]. Additionally, these clinical species appear to have significantly smaller genomes compared to environmental species, which correlates with a reduction in genes involved in plant decay and phytopathogenesis [36]. Such genomic differences explain the adaptive shift of Sporothrix species from a saprobic to a mammalian pathogenic lifestyle, marked by increased pathogenicity during evolution [36]. Investigating genomic variations between environmental and clinical strains could provide valuable insights into how phenotypic and genotypic factors drive evolution and pathogenicity in Sporothrix species.
Whole-genome sequencing (WGS) efforts have contributed significantly to our understanding of the genus Sporothrix by revealing genetic diversity, elucidating evolutionary relationships, and uncovering genes involved in virulence and host adaptation. Genomes of multiple isolates, including S. schenckii, S. brasiliensis, S. globosa, and S. pallida, have been sequenced, enabling robust comparative studies [37,38]. In 2014, Cuomo et al. conducted genome sequencing on the S. schenckii strain ATCC 58251, estimating the genome size at 32.23 Mb, with a GC content of 55.2% [39]. However, a separate study reported the genome sizes of S. schenckii (strain 1099-18) and S. brasiliensis (strain 5110) as 32.4 and 33.2 Mb, respectively [40]. Huang et al. further sequenced two clinical isolates of S. globosa, including one from a patient with therapeutic failure, reporting genome sizes of 33.47 and 33.49 Mb, respectively [38]. A comparative analysis of genomic data from 16 Sporothrix strains, focusing on pathogenicity, revealed that genome assembly sizes range from 33 to 44 Mb. The largest genome was identified in S. pallida, followed by S. globosa, S. brasiliensis and S. schenckii [36].
Regarding the ploidy state of the species within this complex, Torres-Guerrero initially described S. schenckii as diploid, based on DNA content analysis (diphenylamine method), survival to ultraviolet irradiation (UV), chemical mutagenesis, and induction of mitotic recombination [41]. Our group, by flow cytometry analyses, showed that the DNA content of resting cells matched the genome size determined by the WGS. Furthermore, our next-generation sequencing data analysis revealed a monomorphic position at each locus consistent with a haploid allele composition. Overall, these findings supported a haploid state of the S. schenckii analyzed strains, a conclusion reinforced by subsequent studies [28,42]. We have also demonstrated a haploid state in multiple strains of S. brasiliensis, S. globosa, and S. pallida [42]. Taken together, these results suggest that haploidy predominates in the genus.
Despite significant advancements in understanding the genome architecture and biological mechanisms governing the development and function of the S. schenckii complex, forward genetic studies remain limited. Establishing clear links between genes, their expression, and their function is critical for characterizing sporotrichosis pathophysiology, developing effective therapies, predicting clinical outcomes, and explaining the enhanced virulence of S. brasiliensis. Although recent developments, such as the clustered regularly interspaced short palindromic repeats (CRISPR)-associated protein (Cas) gene editing, Agrobacterium tumefaciens-mediated transformation (ATMT), and the generation of Δku80 mutant strains, represent meaningful progress [28,43], the overall toolkit for genetic manipulation remains limited. Continued innovation in genetic manipulation strategies is urgently needed to advance Sporothrix functional genomics [44]. A comparative summary of the current genetic tools available for Sporothrix species is presented in Table 1 and described in the following sections.

3.1. Random Mutagenesis

Classic techniques such as chemical- and UV-induced random mutagenesis provide an easy and efficient strategy to generate mutations selectable by specific traits based on selection/identification methods. These techniques have the potential to generate both gain- and loss-of-function mutations, forming the basis for forward genetic screening [45]. Chemical mutagens take advantage of chemical compounds, such as nitrous acid and N-methyl-N′-nitro-N-nitrosoguanidine (MNNG), to introduce nucleotide substitutions or small deletions. In UV mutagenesis, the UV radiation causes DNA lesions directly or via ROS production, which further damages the DNA structure and amplifies mutation rates. Since these methods induce mutations through chemical or photonic damage, the alterations tend to occur randomly across the genome, where sites prone to replication stress may exhibit elevated mutation frequencies [45].
Torres-Guerreiro and Arenas-Lopez pioneered S. schenckii morphogenesis studies by attempting to obtain mutants using UV-induced random mutagenesis [46]. In this study, two different Mexican human clinical isolates (MP101 and MP102) were used as parental strains to obtain mutants with morphological differences. Exposure to UV doses of 300–1200 ergs/mm2 yielded morphological variants at frequencies from 0.0097 to 0.2, with survival rates of 38–64%. Interestingly, the reproducibility of the mutant phenotype remains unclear, with pleiotropic traits observed, such as altered hyphal morphology, branching, septation, and possible cell wall defects [46]. The authors also evaluated the mutagenic effect of 0.3 M nitrous acid, a base-deaminating agent, but observed mutation frequencies below 0.00001, indicating a markedly lower mutagenic potential than under UV exposure. One of the mutants isolated from S. schenckii, UVM9, showed pleiotropic traits, such as altered shape and size, a reversion frequency of 1 × 10−5 and being avirulent in a murine model [47]. Its altered cell morphology and the impaired polarized growth were suggested to be the result of mutation in any of the tubulin (α or β) genes [47]. However, a definitive link between the genotype and phenotype is missing and could be established by fully sequencing the DNA. Tachibana et al. applied MNNG-induced mutagenesis to strain IFM 41,598 of S. schenckii to assess the role of thermotolerance in visceral infection. After 1 hour (h) exposure to 0.3 mg/mL MNNG, viability dropped by 40%, yet all four selected mutants retained their ability to cause cutaneous lesions even at inocula as low as 10 colony-forming units (CFUs) [48].
Melanin, as already mentioned before, is a virulence factor in many major human pathogenic fungi, and therefore several efforts have been made to create mutants with impaired melanin production in Sporothrix [25]. Romero-Martínez et al. [29] used UV mutagenesis, as described elsewhere [46], on the EH-217 clinical strain of S. schenckii to generate pigment-deficient mutants, identifying two—an albino and a light reddish-brown variant [29]. These authors were the first to provide molecular evidence that S. schenckii synthesizes melanin via the DHN melanin pathway. This molecular manipulation also revealed that melanized cells were more resistant to oxidative killing and phagocytosis by human and murine immune cells [29,49]. In S. globosa, Song et al. [50] applied UV mutagenesis to investigate the immunomodulatory role of melanin. Melanin-deficient mutants were more susceptible to ROS and NO and induced higher levels of TNF-α and IL-6 in macrophages. Additionally, melanin downregulated TLR2 and TLR4 expression, thereby limiting innate immune activation [50].
Despite the importance of studying virulence factors, such as those cited above, producing auxotrophic mutants is a crucial step for advancing molecular tools for genetic research and selection experiments. Notably, Torres-Guerrero found significant difficulties in isolating these types of mutants using UV radiation or nitrous acid as mutagenic agents. In fact, only by using a two-step mutagenesis protocol with nitrous acid and UV radiation were auxotrophic mutants produced for adenine and methionine [41]. The inability to obtain auxotrophic mutants is still poorly understood, as the applied techniques are widely used to successfully obtain auxotrophic mutants in haploid organisms due to their recessive nature. Overall, the utilization of these random mutagenesis approaches, once standard, lost popularity due to challenges in correlating genotype to phenotype. However, the cost-effectiveness of WGS has renewed its value, making it a practical tool for dissecting gene function and virulence pathways in Sporothrix species, especially considering the haploid state of these species. Nevertheless, comprehensive transcriptomic and proteomic datasets are limited, which restricts the functional interpretation of genomic information. This highlights the need for an integrated, multi-omics approach to fully elucidate gene expression, protein regulation, and virulence mechanisms in this genus.

3.2. Genetic Transformation

Cell transformation involves the integration of exogenous DNA into a cell, being a pivotal technique in molecular biology, enabling functional genomics and deeper insights into microbial pathophysiology. This phenomenon was first demonstrated in 1928 by Frederick Griffith, who showed that non-virulent Streptococcus pneumoniae could be transformed into a virulent form through exposure to heat-killed virulent strains. Since then, transformation methodologies have been extensively refined, broadening their trans-kingdom applicability [51]. However, the genetic transformation of Sporothrix species remains particularly challenging due to their complex and variable cell wall structures and unique genomic features, which often result in low transformation efficiency and unpredictable DNA integration. Additionally, the chemical composition of the fungal cell wall can vary significantly between species, strains, and even under different environmental or growth conditions, further posing challenges to establishing standardized transformation protocols for Sporothrix species [28,43,52].

3.2.1. Protoplast-Mediated Transformation

Protoplast-mediated transformation (PMT) is a widely used technique for genetic manipulation of filamentous fungi. This method involves enzymatic degradation of the fungal cell wall to produce protoplasts, which are then exposed to exogenous DNA under controlled osmotic conditions [53]. Due to their increased sensitivity to osmotic pressure and environmental stresses, protoplast preparation requires isotonic conditions maintained with specific salts or sugars to prevent cell lysis throughout the transformation procedure. Several factors govern the efficiency of protoplast generation and transformation, including the type and concentrations of enzymes, choice of osmotic stabilizers, digestion time and incubation temperature, fungal growth phase and mycelial age [53]. Enzymatic cocktails often contain β-glucanases, cellulases, proteases, chitinases, and α-(1,3)-glucanases, among other enzymes, for their ability to degrade diverse fungal cell wall polymers. Osmotic stabilizers like sorbitol, potassium chloride, and sodium chloride are commonly used to prevent fungal cell membrane rupture during transformation [28,53]. Polyethylene glycol (PEG) facilitates protoplast transformation by transiently enhancing the uptake of exogenous DNA into fungal cells. As an amphiphilic molecule, PEG stabilizes the membrane structure, increases membrane permeability, and promotes recovery after transformation. PEG variants commonly used include PEG 3350, PEG 6000, and PEG 8000. Higher molecular weight PEG variants increase the stability of the formed structures and reduce their toxicity; however, they significantly decrease membrane permeability. PEG is a key element in the transformation protocols, and the choice of its molecular weight directly influences the efficiency of transformation. Therefore, the choice of PEG must be carefully optimized for each fungal species to achieve the best results [53].
Rodriguez-Caban et al. developed a PMT protocol for the yeast-phase S. schenckii, adapting methods initially designed for Ophiostoma species [14]. Actively growing yeast cells were pre-treated with β-mercaptoethanol (25 mM; 1 h), which reduces disulfide bonds in cell wall proteins, thereby increasing their sensitivity to enzymatic degradation. Following the thiol step, protoplast release was induced using a mixture of β-1,3-glucanase enzymes (Glucanex®; 10 mg/mL, 2 h, 25 °C) in MgSO4 solution (1 M). In addition, sorbitol (1 M) was used to maintain protoplast integrity. For DNA transformation, approximately 108 protoplasts were subjected to a PEG3350/CaCl2-mediated genetic transformation system. A total of 10 μg of DNA (pSD2G; plasmid-based vector) was mixed with denatured salmon sperm DNA (0.4 mg/mL). Protoplast recovery was carried out in M medium (1 M sorbitol), and transformants were selected using geneticin (500 μg/mL) as a selection marker. While this protocol enabled the genetic transformation of S. schenckii, the transformation efficiency was relatively low, yielding approximately 21–24 transformants per µg of DNA [14].
PEG-mediated DNA transformation of protoplasts using PEG8000 and sorbitol as the osmotic stabilizer has been applied by several authors. This protocol enabled the incorporation of DNA fragments containing either hygromycin B phosphotransferase gene (hph), which confers resistance to hygromycin B, or nourseothricin N-acetyl transferase (nat) into the Sporothrix genome, which are commonly used as selectable marks in genetic transformation of Sporothrix [28,43,54]. Unlike the protocol developed by Rodriguez-Caban et al. [14], which used the yeast phase, this method was specifically optimized for the filamentous form of the fungus [28]. Mycelia were pre-treated with Dithiothreitol (DTT; 10 mM) in citrate/phosphate buffer (90 mM; pH 7.3; 1 h; 25 °C) to reduce disulfide bridges (similar effect to β-mercaptoethanol). Protoplast release was achieved through enzymatic digestion of the cell wall using a mixture of Yatalase and lysing enzymes from Trichoderma harzianum for 90 min. For transformation, 5 × 105 to 2 × 106 protoplasts were suspended in a solution containing 50 mM CaCl2, 0.6 M KCl, 0.1 M Tris/HCl, pH 7.5, mixed with 25% PEG 8000 and 1.5 µg of DNA. After 25 min of incubation, additional PEG was added, and protoplasts were allowed to recover overnight in Sabouraud medium supplemented with 1.2 M sorbitol (pH 4.5) [28]. Transformants were selected using nourseothricin (80 µg/mL) or hygromycin B (180 µg/mL) as selection markers. This procedure was developed for CRISPR/Cas9 genome editing, and therefore, no transformation efficiency was reported.
Protoplast-mediated transformation is a versatile and effective method for fungal genetic engineering. Successful transformation depends on the fine-tuning of enzymatic treatments, osmotic conditions, PEG properties, and the fungal growth phase. Case studies in Sporothrix species highlight the adaptability of PMT (Figure 1A) across different fungal morphologies and its compatibility with advanced genome manipulation tools.

3.2.2. Agrobacterium Tumefaciens-Mediated Transformation (ATMT)

Agrobacterium tumefaciens is a Gram-negative soil bacterium best known for its natural capacity to transfer T-DNA from its tumor-inducing (Ti) plasmid into plant host genomes, leading to crown gall disease. This unique DNA transfer system has been repurposed as a genetic transformation tool across kingdoms, including fungi [55]. A key advantage of ATMT is its ability to genetically manipulate intact fungal cells, including conidia and mycelia, without requiring protoplast generation [52]. Following the demonstration by the Hooykaas group of T-DNA transfer to Saccharomyces cerevisiae, ATMT has been widely applied in fungal genetics to investigate traits such as virulence, sporulation, and antimicrobial resistance, among others [56].
The genetic background of A. tumefaciens is known to contribute to the efficiency of the ATMT system, as the bacterium’s ability to recognize and bind to the host surface depends on genes encoded within its genome. In a seminal study, A. tumefaciens strains LBA4404, EHA105, and AGL-1, each harboring the binary vector pBHt1 carrying the hph gene, were used to transform a clinical isolate of S. schenckii from China [52]. The transformation protocol developed was as follows: A. tumefaciens strains were cultured overnight in LB liquid medium (20 µg/mL rifampicin and 100 µg/mL kanamycin; 28 °C) until reaching an optical density (OD600) of 0.6–0.8. Washed cells were then transferred to induction medium (IM) composed of K-buffer, MN buffer, 1% CaCl2·2H2O, 0.01% FeSO4, 20% NH4NO3, 50% glycerol, 1 M MES (pH 5.5), and 20% glucose and incubated for 8 h at 28 °C for induction of the virulence genes. Meanwhile, S. schenckii was cultured on potato dextrose agar (PDA) for 7 days at 25 °C to induce sporulation. Conidia were harvested and adjusted to a final concentration of 5 × 106 conidia/mL in IM. For the co-cultivation step, A. tumefaciens cells were mixed with an equal volume of fungal conidial suspension on solid IM plates supplemented with acetosyringone to promote T-DNA transfer. All three bacterial strains yielded transformants, though A. tumefaciens AGL-1 gave a higher transformation efficiency, achieving over 600 transformants per 106 conidia, thereby identifying it as the most effective strain for this system [52]. Building on these findings, Lozoya-Pérez et al. [54] further refined the ATMT system using A. tumefaciens AGL-1 carrying pBGgHg, a vector encoding hph and a green fluorescent protein (GFP). The transformation was performed on the WT S. schenckii 1099-18 (ATCC MYA 4821). A reduced induction time of 4.5 h with IM yielded a similar transformation efficiency to previous protocols, producing approximately 722 ± 48 transformants per 106 conidia [54]. In 2023, the ATMT platform was successfully extended to S. brasiliensis [43]. Multiple strains of A. tumefaciens (AGL-1, EHA105, LBA1100) carrying the hph marker were tested at varying fungal-to-bacterial ratios (1:1 and 1:2) and incubation durations (24, 48, 72 h). The S. brasiliensis yeast cell concentration was standardized to 1 × 108 cells/mL. Among the tested conditions, the A. tumefaciens AGL-1 co-cultured at a 2:1 ratio for 48–72 h at 26 °C produced the highest transformation efficiency [43]. Real-time PCR analysis of transformants confirmed stable genomic integration of a single T-DNA copy. All these data confirmed that the ATMT system (Figure 1B) is an effective method for transforming Sporothrix species, although it is limited by the fact that integration occurs at random genomic locations.

3.3. Gene Silencing

Gene silencing techniques have emerged as vital tools to elucidate the molecular mechanisms governing the pathogenicity of several fungal pathogens, including those of Sporothrix species. Early work primarily focused on S. schenckii, where RNA interference (RNAi) was employed to investigate the function of key virulence-associated genes. A pioneer study by Rodriguez-Caban et al. on S. schenckii confirmed the presence of core RNAi machinery through the identification of a Dicer-1 homolog, laying the groundwork for functional gene silencing experiments [14]. Subsequent functional analyses exploited RNAi to silence genes implicated in key pathogenic processes. One of the earliest targets was the calcium/calmodulin kinase I (SSCMK1) gene [14]. These authors used pSD2G [57] and the protoplast transformation system to express 405 bp (3′ region) and 432 bp (5′ region) fragments of the SSCMK1 gene. The isolated silenced mutantes exhibited an approximately 60% reduction in SSCMK1 gene expression. This silencing system showed the relevance of this gene for thermotolerance and interaction with HSP90 (two-hybrid screening), two critical factors for fungal survival and adaptation to mammalian body temperature [14]. Although orthologs of this kinase are present in S. brasiliensis, their precise functional roles remain to be elucidated. Complementing this pathway, DRK1 (Dimorphism-Regulating Kinase 1), a hybrid histidine kinase, acts as a master regulator of dimorphism and virulence. The SsDRK1 gene in S. schenckii is highly expressed in the yeast phase, and its silencing leads to defects in cell wall synthesis, abnormal morphogenesis, reduced growth in both yeast and mycelial forms, and attenuated virulence in infection models [58,59]. These findings position DRK1 as a conserved and critical regulator in fungal dimorphism across thermally dimorphic pathogens.
Lozoya-Pérez et al. further exploited this tool and used ATMT to target the OCH1 gene, involved in N-linked glycosylation, a process critical for cell wall integrity and immune evasion [60]. These authors designed an RNA hairpin structure composed of a 444 bp hairpin stem of OCH1 (from position +54 to +497). The sense and antisense sequences flanked a spacer region consisting of an intron from the cutinase gene of the rice blast fungus, Magnaporthe oryzae [61]. With this strategy, the authors were able to reduce OCH1 expression in S. schenckii by 43–99%. In addition, silencing OCH1 in S. schenckii revealed alterations in cell wall composition, which correlated with reduced virulence and impaired interaction with host immune cells, thus emphasizing the role of glycosylation pathways in pathogenesis. Similarly, RNAi targeting the ROT2 gene, a crucial enzyme for the maturation of N-linked glycan precursors, which encodes the catalytic subunit of endoplasmic reticulum α-glucosidase II, was also applied using the same strategy [24].
Gp70 gene silencing in S. schenckii revealed its critical role in fungal adhesion, virulence, and modulation of host immune responses, underscoring the importance of this glycoprotein in pathogenesis [20]. López-Ramírez et al. used the same strategy as described above but reduced the hairpin stem to a 295 bp fragment targeting GP70, without affecting the silencing efficiency [20]. The results demonstrated that different levels of Gp70 expression modulated cell wall composition, namely reduced mannose, rhamnose, and protein levels, with increased β-1,3-glucan contents. The adhesin and 3-carboxy-cis, cis-muconate cyclase properties of Gp70 highlight the versatility of this protein in the fungus-host interaction. Pap1 is a recently characterized moonlighting protein found in the cell wall of S. schenckii, bound to peptidorhamnomannan (PRM) [23]. Given the limited knowledge of the N-linked glycosylation pathway in Sporothrix species, López-Ramírez et al. investigated the role of ROT2, where they generated ROT2-silenced strains displaying intermediate to high silencing levels, ranging from 59.3 ± 10.6% to 99.6 ± 0.1% [24]. Silencing led to the accumulation of the immature glycan core Glc2Man9GlcNAc2 and a concomitant reduction in total N-linked glycan content in the fungal cell wall. A compensatory increase in O-linked glycan synthesis was described, proportional to the degree of ROT2 silencing.
In a seminal work, Padró-Villegas et al. extended this research to S. brasiliensis [62]. Silencing Gp70 in S. brasiliensis involved a similar strategy as described above, with a 295 bp fragment of the 5′ end of the GP70, and transformation was Agrobacterium-mediated. The Gp70 silencing in S. brasiliensis resulted in morphological changes, including smaller, round yeast cells prone to aggregation. Cell wall analyses revealed increased β-1,3-glucan exposure and diminished N-linked glycan content, which likely contributed to altered immune recognition. Furthermore, mutants showed decreased enzymatic activity of 3-carboxy-cis, cis-muconate cyclase, impaired adhesion to laminin and fibronectin, and modified cytokine responses upon interaction with human peripheral blood mononuclear cells. These alterations culminated in attenuated virulence in the G. mellonella infection model [62]. This landmark study represents the first RNAi application in S. brasiliensis and establishes a functional link between Gp70 and fungal pathogenicity.
RNAi-based gene silencing has proven to be an effective and relatively accessible tool for functional studies in Sporothrix, particularly given the early-stage development of advanced genetic tools in this genus. Its main strengths lie in the ability to achieve graded knockdown of gene expression without requiring gene disruption, which is especially advantageous when targeting essential genes. However, this approach presents several limitations, including variable silencing efficiency, the potential for off-target effects, and challenges in achieving complete gene suppression. Furthermore, the construction of hairpin RNA vectors and reliance on transformation systems such as ATMT or PMT may restrict their widespread application, especially in strains or laboratories with limited genetic tools. Despite these limitations, RNAi remains a valuable strategy for target validation and functional genomics, particularly in Sporothrix, where CRISPR-based editing is only beginning to emerge. The growing number of successful RNAi applications in both S. schenckii and S. brasiliensis underline its potential as a bridge between classical and modern molecular fungal biology.

3.4. Gene Editing

Gene editing enables precise modifications to the genome sequences, offering a powerful tool for understanding and manipulating genetic functions. Among these technologies, the CRISPR system has emerged as one of the most efficient gene-editing methods. Originally discovered as an endogenous immune defense mechanism of bacteria and archaea against invading viruses [63], the CRISPR system has since been repurposed as a powerful biotechnology tool that enables gene replacement, deletion, and insertion in both eukaryotic and prokaryotic organisms. To date, three CRISPR system types (I-III) have been identified, with type II being the most widely used and well-characterized. This type relies on a single protein nuclease for DNA cleavage. First introduced in Saccharomyces cerevisiae [64], the CRISPR/Cas system has revolutionized genetic studies in fungi, including filamentous fungi [65]. The selection of transformants often relies on positive selection markers, namely resistance markers or nutrient deficiency genes, though options for filamentous fungi remain limited [65].
CRISPR-based tools have emerged as pivotal in the targeted genetic manipulation of pathogenic Sporothrix species, S. brasiliensis and S. schenckii, particularly in understanding their virulence mechanisms [28]. The internalization of CRISPR/Cas9 protein complexes assembled with guide RNAs (gRNAs) via PEG-mediated protoplast transformation enables precise gene editing. This was exemplified by the deletion of the pks1 gene, which encodes 1,3,6,8-tetrahydroxynaphthalene synthase, in Sporothrix species [28]. The gene-editing strategy relied on the integration of a cassette carrying either nourseothricin or hygromycin B resistance markers, each flanked by approximately 850 bp of homology region positioned upstream and downstream of the Cas9 enzyme cleavage sites at the targeted gene. For this purpose, the EnGen Spy Cas9 NLS was guided with two different gRNAs, locating the Cas9 at the starting and ending regions of the open reading frame. Hatinguais and colleagues increased the efficiency of cassette integration through homologous recombination by using strains null for KU80 homolog (SPBR_02356 and SPSK_07043). The deletion of KU80 impairs non-homologous end-joining (NHEJ) DNA repair pathway, thereby favoring homologous recombination, as has been described for other systems [66]. The full gene-editing protocol begins with the cultivation of Sporothrix species in Sabouraud dextrose broth at 25 °C to obtain actively growing mycelia. The protoplasts are generated by enzymatic digestion using Yatalase and Lysing Enzymes from Trichoderma harzianum in a maleic acid-based buffer. These protoplasts are then incubated with preassembled Cas9/gRNA ribonucleoprotein complexes along with linearized donor DNA. Transformation is carried out using PEG 8000 in a Tris-HCl buffer supplemented with CaCl2. Regeneration is performed in sorbitol-containing Sabouraud medium, and transformants are selected using either nourseothricin or hygromycin B resistance.
These seminal advances address the historical lack of molecular tools for reverse genetics in these fungi, representing a critical step towards understanding the virulence mechanisms of Sporothrix species and providing a foundation for further functional studies. This technique, when fully applied in Sporothrix studies, will allow a remarkable evolution in our understanding of these pathogens and their associated diseases.

3.5. Heterologous Expression for Functional Gene Analysis

Filamentous fungi serve as versatile platforms for heterologous gene expression, offering valuable insights into gene function and facilitating the elucidation of biosynthetic pathways. Their capacity to accommodate and express genes from diverse organisms makes them indispensable tools in functional genomics and natural product research. The use of forward genetics approaches, particularly through functional complementation using mutant libraries such as the S. cerevisiae Euroscarf collection or Candida species mutants, is highly valuable for elucidating gene function. Currently, the repertoire of tools available for understanding gene function and relevance in Sporothrix is limited. In pathogenic fungi such as S. schenckii, heterologous expression has been instrumental in characterizing genes involved in glycosylation pathways. For instance, a genome-wide screening identified several S. schenckii genes belonging to glycosyl hydrolase families 47 and 63. These genes were individually expressed in C. albicans null mutants lacking specific glycosidase genes. Restoration of N-linked glycosylation-associated mutant phenotypes confirmed their functional role in glycan maturation [67]. Furthermore, heterologous expression of Sporothrix schenckii KTR4 and KTR5, members of the MNT1/KRE2 gene family, in Candida albicans null mutants resulted in functional complementation of N-linked glycosylation defects, confirming the roles of these Sporothrix genes as Golgi-resident mannosyltransferases [68]. Similarly, the isolation and characterization of the S. schenckii ROT2 gene is crucial for N-linked glycosylation. Robledo-Ortiz et al. demonstrated that this gene could partially restore the phenotype in an S. cerevisiae rot2Δ mutant, underscoring its functional conservation and potential for studying glycosylation processes in pathogenic fungi [69]. Further, the GFA1 gene from S. schenckii, encoding glucosamine-6-phosphate synthase—a key enzyme in amino sugar biosynthesis—was successfully cloned and expressed in an S. cerevisiae gfa1Δ mutant. The heterologously expressed gene not only restored prototrophy but also resulted in enzyme activity with improved stability and resistance to product inhibition, suggesting biotechnological advantages [70].
The potential of this genetic approach was also demonstrated through the expression of two cell wall proteins from S. schenckii, Hsp60 and PRM-associated protein 1 (Pap1), in E. coli. These proteins, components of the PRM complex, exhibited adhesive properties to ECM proteins and activated immune responses in invertebrate models, positioning them as promising candidates for immunological studies [23]. Tavares et al. also developed a plasmid toolkit for Sporothrix species that enables fusion of endogenous genes to fluorescent markers such as sGFP and mCherry. The toolkit allowed precise subcellular localization studies, exemplified by the successful nuclear targeting of a histone H2A fusion protein under the control of the pGAPDH promoter, in both yeast and mycelial forms of the fungus [43]. Similarly, Hatinguais et al. [28] demonstrated that PMT is a reliable method for expressing exogenous genes, such as a synthetic, red-shifted luciferase. Combined with CRISPR/Cas9 technology, this system provided a robust platform for investigating fungal viability under ROS stress and represents a promising approach for in vivo virulence studies [28].
Although heterologous expression has proven to be a valuable tool for elucidating gene function in Sporothrix species, functional conservation across hosts does not always guarantee accurate phenotypic outcomes. Differences in codon usage between the donor and host organism can reduce protein accumulation and affect protein folding and stability, thereby influencing the resulting phenotypes. Additionally, proteins expressed in a heterologous system may acquire host-dependent additional or moonlighting functions that are absent in the native context, further complicating functional interpretation. Despite these limitations, heterologous expression remains a critical tool in fungal functional genomics, particularly given the technical constraints associated with genetic manipulation in Sporothrix spp. It has provided insights into glycosylation pathways, cell wall protein function, subcellular localization, responses to stress, and the development of versatile platforms for immunological and in vivo virulence studies.

4. Future Perspectives

The ongoing development of molecular tools for Sporothrix species marks a pivotal step toward unraveling the genetic basis of virulence, host adaptation, and antifungal resistance in this genus. Despite notable advancements—such as the establishment of PEG-mediated protoplast transformation, ATMT and CRISPR/Cas9-based gene editing—the toolkit for efficient and targeted genetic manipulation remains relatively limited compared to model fungal pathogens.
One of the most transformative recent breakthroughs has been the implementation of a CRISPR/Cas9 system optimized for S. brasiliensis using PEG-mediated transformation. This system enabled precise deletion of the pks1 gene and demonstrated enhanced editing efficiency in ∆ku80 mutants, which exhibit impaired NHEJ and improved homologous recombination rates [28]. Building upon this foundation, future studies should expand gene targeting strategies to include genes involved in immune evasion, biofilm formation, and metabolic adaptation, which are central to the success of pathogens in both environmental and host-associated niches. Given the demonstrated utility of fluorescently or luminescently tagged strains [28,43,54] the next logical step involves leveraging these strains in live imaging and host–pathogen interaction models. Tagging known or suspected virulence genes with fluorescent markers in vivo will facilitate dynamic studies of fungal dissemination, tissue tropism, and immune evasion in real time. Another promising avenue is the integration of transcriptomic and proteomic data with reverse genetics. In fact, coupling CRISPR/Cas9 mutagenesis with RNA-Seq or proteome-wide screens can help map regulatory networks and uncover condition-specific gene functions. Furthermore, introducing CRISPR interference (CRISPRi) or activation (CRISPRa) systems, coupled with Tet-On/Tet-Off regulation, would allow fine-tuned, reversible control of gene expression, critical for essential genes or subtle phenotypic traits [71]. Moreover, the development of self-replicating plasmid systems will be crucial, as they have proven effective in other fungal pathogens for increasing transformation efficiency and enabling precise genetic manipulation. These plasmids, particularly in their linear form, have demonstrated the ability to increase the yield of autonomous transformants and support stable gene expression without chromosomal integration. Applying such technologies to Sporothrix could overcome current limitations in genetic transformation and accelerate functional genomics studies. Future research should focus on identifying or engineering replication origins compatible with Sporothrix species, optimizing transformation protocols, and validating the use of episomal vectors in these fungi.
In summary, the field of Sporothrix research is undergoing a critical transition, from largely descriptive studies to a functional genomics era driven by advanced molecular tools. Collectively, the molecular toolbox for Sporothrix species now includes transformation systems (protoplast-mediated and Agrobacterium tumefaciens-mediated), gene silencing (RNAi), CRISPR/Cas9-based gene editing, heterologous expression platforms, and fluorescent/luminescent reporter systems. While each tool has typically been used in isolation to address specific questions, its true potential lies in their integration. For instance, CRISPR-mediated gene disruption can be combined with fluorescent tagging to study dynamic localization, while RNAi or CRISPRi can enable tunable knockdowns in essential genes. Heterologous expression further facilitates functional validation in genetically tractable hosts. These complementary approaches allow researchers to dissect complex traits—such as virulence, immune evasion, or metabolic adaptation—through direct manipulation and surrogate modeling. A coherent strategy that harnesses multiple tools will accelerate the transition from gene identification to mechanistic understanding in this emerging pathogen.

Author Contributions

Conceptualization, F.R.; methodology, M.B., M.T., R.S., R.P.d.S. and F.R.; formal analysis, M.B., M.T., R.S., R.P.d.S. and F.R.; investigation, M.B., M.T., R.S., R.P.d.S. and F.R.; resources, F.R.; data curation, M.B., M.T., R.S., R.P.d.S. and F.R.; writing—original draft preparation, M.B.; writing—review and editing, F.R., R.S., R.P.d.S.; visualization, M.B. and M.T.; supervision, project administration and funding acquisition, F.R. All authors have read and agreed to the published version of the manuscript.

Funding

This research received funding from NORTE2030-FEDER-00717300 (https://doi.org/10.54499/2023.16204.ICDT), through NORTE 2030 program in FEDER and FCT.

Institutional Review Board Statement

Not applicable.

Informed Consent Statement

Not applicable.

Data Availability Statement

No new data were created or analyzed in this study. Data sharing is not applicable to this article.

Acknowledgments

This work has been funded by national funds, through the Foundation for Science and Technology (FCT), under projects UID/06304/2025 (https://doi.org/10.54499/UID/06304/2025) and LA/P/0050/2020 (https://doi.org/10.54499/LA/P/0050/2020), as well as with the references 2024.02034.BD and 2023.01913.BD to M.B. and M.T. In addition, F.R. and R.S. were supported by NORTE2030-FEDER-00717300 (https://doi.org/10.54499/2023.16204.ICDT) through NORTE 2030 program in FEDER and FCT. This work has been funded by national funds through the Foundation for Science and Technology (FCT) under projects UID/06304/2025 (https://doi.org/10.54499/UID/06304/2025) and LA/P/0050/2020 (https://doi.org/10.54499/LA/P/0050/2020). This manuscript benefited from the use of ChatGPT 4o (OpenAI, San Francisco, CA, USA) for English language refinement, text editing and figure improvement. The authors reviewed and approved all AI-assisted language refinement and text editing.

Conflicts of Interest

The authors declare no conflicts of interest.

Abbreviations

The following abbreviations are used in this manuscript:
ATMTAgrobacterium tumefaciens-mediated transformation
CaMCalmodulin
CaMKsCalmodulin-dependent protein kinases
CFUsColony-forming units
CRISPRClustered regularly interspaced short palindromic repeats
DHN1,8-dihydroxynaphthalene
DRK1Dimorphism-Regulating Kinase 1
DTTDithiothreitol
ECMExtracellular matrix
EVsExtracellular vesicles
GFPGreen fluorescent protein
GpGlycoprotein
gRNAsGuide RNAs
hHour
hphHygromycin B phosphotransferase gene
HSPsHeat shock proteins
ILInterleukin
IMInduction medium
minMinutes
MNNGN-methyl-N′-nitro-N-nitrosoguanidine
natNourseothricin N-acetyl transferase gene
NHEJNon-homologous end-joining
NONitric oxide
ODOptical density
Pap1Peptidorhamnomannan-associated protein 1
PEGPolyethylene glycol
PMTProtoplast-mediated transformation
PRMPeptidorhamnomannan
RNAiRNA interference
ROSReactive oxygen species
SSCMK1calcium/calmodulin kinase I
TiTumor-inducing
TLRToll-like receptor
TNF-αTumor necrosis factor alpha
UVUltraviolet irradiation
WTWild-type
WGSWhole-genome sequencing

References

  1. Machado, T.C.; Gonçalves, S.S.; De Carvalho, J.A.; Bonifaz, A.; Brilhante, R.S.N.; De Camargo, Z.P.; Rodrigues, A.M. Insights from Cutting-Edge Diagnostics and Epidemiology of Sporotrichosis and Taxonomic Shifts in Sporothrix. Curr. Fungal Infect. Rep. 2025, 19, 3. [Google Scholar] [CrossRef]
  2. Barros, M.B.D.L.; De Almeida Paes, R.; Schubach, A.O. Sporothrix schenckii and Sporotrichosis. Clin. Microbiol. Rev. 2011, 24, 633–654. [Google Scholar] [CrossRef] [PubMed]
  3. Fuchs, T.; Visagie, C.M.; Wingfield, B.D.; Wingfield, M.J. Sporothrix and Sporotrichosis: A South African Perspective on a Growing Global Health Threat. Mycoses 2024, 67, e13806. [Google Scholar] [CrossRef]
  4. Rodrigues, A.M.; De Hoog, G.S.; De Camargo, Z.P. Sporothrix Species Causing Outbreaks in Animals and Humans Driven by Animal–Animal Transmission. PLoS Pathog. 2016, 12, e1005638. [Google Scholar] [CrossRef]
  5. Xavier, M.O.; Poester, V.R.; Trápaga, M.R.; Stevens, D.A. Sporothrix brasiliensis: Epidemiology, Therapy, and Recent Developments. J. Fungi 2023, 9, 921. [Google Scholar] [CrossRef] [PubMed]
  6. Poester, V.R.; Xavier, M.O.; Munhoz, L.S.; Basso, R.P.; Zancopé-Oliveira, R.M.; Freitas, D.F.S.; Pasqualotto, A.C. Sporothrix Brasiliensis Causing Atypical Sporotrichosis in Brazil: A Systematic Review. J. Fungi 2024, 10, 287. [Google Scholar] [CrossRef]
  7. Do Monte Alves, M.; Pipolo Milan, E.; Da Silva-Rocha, W.P.; Soares De Sena Da Costa, A.; Araújo Maciel, B.; Cavalcante Vale, P.H.; De Albuquerque, P.R.; Lopes Lima, S.; Salles De Azevedo Melo, A.; Messias Rodrigues, A.; et al. Fatal Pulmonary Sporotrichosis Caused by Sporothrix brasiliensis in Northeast Brazil. PLoS Negl. Trop. Dis. 2020, 14, e0008141. [Google Scholar] [CrossRef]
  8. Gremião, I.D.F.; Miranda, L.H.M.; Reis, E.G.; Rodrigues, A.M.; Pereira, S.A. Zoonotic Epidemic of Sporotrichosis: Cat to Human Transmission. PLoS Pathog. 2017, 13, e1006077. [Google Scholar] [CrossRef]
  9. García-Carnero, L.C.; Martínez-Álvarez, J.A. Virulence Factors of Sporothrix schenckii. J. Fungi 2022, 8, 318. [Google Scholar] [CrossRef]
  10. Kischkel, B.; Lopes-Bezerra, L.; Taborda, C.P.; Joosten, L.A.B.; Dos Santos, J.C.; Netea, M.G. Differential Recognition and Cytokine Induction by the Peptidorhamnomannan from Sporothrix brasiliensis and S. schenckii. Cell. Immunol. 2022, 378, 104555. [Google Scholar] [CrossRef] [PubMed]
  11. Gómez-Gaviria, M.; Martínez-Álvarez, J.A.; Mora-Montes, H.M. Current Progress in Sporothrix brasiliensis Basic Aspects. J. Fungi 2023, 9, 533. [Google Scholar] [CrossRef] [PubMed]
  12. Teixeira, P.A.C.; De Castro, R.A.; Nascimento, R.C.; Tronchin, G.; Pérez Torres, A.; Lazéra, M.; De Almeida, S.R.; Bouchara, J.-P.; Loureiro, Y.; Penha, C.V.; et al. Cell Surface Expression of Adhesins for Fibronectin Correlates with Virulence in Sporothrix schenckii. Microbiology 2009, 155, 3730–3738. [Google Scholar] [CrossRef] [PubMed]
  13. Valle-Aviles, L.; Valentin-Berrios, S.; Gonzalez-Mendez, R.R.; Rodriguez-del Valle, N. Functional, Genetic and Bioinformatic Characterization of a Calcium/Calmodulin Kinase Gene in Sporothrix schenckii. BMC Microbiol. 2007, 7, 107. [Google Scholar] [CrossRef] [PubMed]
  14. Rodriguez-Caban, J.; Gonzalez-Velazquez, W.; Perez-Sanchez, L.; Gonzalez-Mendez, R.; Valle, N.R. Calcium/Calmodulin Kinase1 and Its Relation to Thermotolerance and HSP90 in Sporothrix schenckii: An RNAi and Yeast Two-Hybrid Study. BMC Microbiol. 2011, 11, 162. [Google Scholar] [CrossRef]
  15. Ene, I.V.; Adya, A.K.; Wehmeier, S.; Brand, A.C.; MacCallum, D.M.; Gow, N.A.R.; Brown, A.J.P. Host Carbon Sources Modulate Cell Wall Architecture, Drug Resistance and Virulence in a Fungal Pathogen. Cell Microbiol. 2012, 14, 1319–1335. [Google Scholar] [CrossRef]
  16. Lozoya-Pérez, N.E.; Clavijo-Giraldo, D.M.; Martínez-Duncker, I.; García-Carnero, L.C.; López-Ramírez, L.A.; Niño-Vega, G.A.; Mora-Montes, H.M. Influences of the Culturing Media in the Virulence and Cell Wall of Sporothrix schenckii, Sporothrix brasiliensis, and Sporothrix Globosa. J. Fungi 2020, 6, 323. [Google Scholar] [CrossRef]
  17. Villalobos-Duno, H.L.; Barreto, L.A.; Alvarez-Aular, Á.; Mora-Montes, H.M.; Lozoya-Pérez, N.E.; Franco, B.; Lopes-Bezerra, L.M.; Niño-Vega, G.A. Comparison of Cell Wall Polysaccharide Composition and Structure between Strains of Sporothrix schenckii and Sporothrix brasiliensis. Front. Microbiol. 2021, 12, 726958. [Google Scholar] [CrossRef]
  18. Lima, O.C.; Figueiredo, C.C.; Previato, J.O.; Mendonça-Previato, L.; Morandi, V.; Lopes Bezerra, L.M. Involvement of Fungal Cell Wall Components in Adhesion of Sporothrix schenckii to Human Fibronectin. Infect. Immun. 2001, 69, 6874–6880. [Google Scholar] [CrossRef]
  19. Ruiz-Baca, E.; Toriello, C.; Pérez-Torres, A.; Sabanero-López, M.; Villagómez-Castro, J.C.; López-Romero, E. Isolation and Some Properties of a Glycoprotein of 70 kDa (Gp70) from the Cell Wall of Sporothrix schenckii Involved in Fungal Adherence to Dermal Extracellular Matrix. Med. Mycol. 2009, 47, 185–196. [Google Scholar] [CrossRef]
  20. López-Ramírez, L.A.; Martínez-Álvarez, J.A.; Martínez-Duncker, I.; Lozoya-Pérez, N.E.; Mora-Montes, H.M. Silencing of Sporothrix schenckii GP70 Reveals Its Contribution to Fungal Adhesion, Virulence, and the Host–Fungus Interaction. J. Fungi 2024, 10, 302. [Google Scholar] [CrossRef]
  21. Rodrigues, A.M.; Kubitschek-Barreira, P.H.; Fernandes, G.F.; De Almeida, S.R.; Lopes-Bezerra, L.M.; De Camargo, Z.P. Immunoproteomic Analysis Reveals a Convergent Humoral Response Signature in the Sporothrix schenckii Complex. J. Proteom. 2015, 115, 8–22. [Google Scholar] [CrossRef]
  22. Castro, R.A.; Kubitschek-Barreira, P.H.; Teixeira, P.A.C.; Sanches, G.F.; Teixeira, M.M.; Quintella, L.P.; Almeida, S.R.; Costa, R.O.; Camargo, Z.P.; Felipe, M.S.S.; et al. Differences in Cell Morphometry, Cell Wall Topography and Gp70 Expression Correlate with the Virulence of Sporothrix brasiliensis Clinical Isolates. PLoS ONE 2013, 8, e75656. [Google Scholar] [CrossRef]
  23. García-Carnero, L.C.; Salinas-Marín, R.; Lozoya-Pérez, N.E.; Wrobel, K.; Wrobel, K.; Martínez-Duncker, I.; Niño-Vega, G.A.; Mora-Montes, H.M. The Heat Shock Protein 60 and Pap1 Participate in the Sporothrix schenckii-Host Interaction. J. Fungi 2021, 7, 960. [Google Scholar] [CrossRef]
  24. López-Ramírez, L.A.; Martínez-Duncker, I.; Márquez-Márquez, A.; Vargas-Macías, A.P.; Mora-Montes, H.M. Silencing of ROT2, the Encoding Gene of the Endoplasmic Reticulum Glucosidase II, Affects the Cell Wall and the Sporothrix schenckii–Host Interaction. J. Fungi 2022, 8, 1220. [Google Scholar] [CrossRef]
  25. Almeida-Paes, R.; Borba-Santos, L.P.; Rozental, S.; Marco, S.; Zancopé-Oliveira, R.M.; Da Cunha, M.M.L. Melanin Biosynthesis in Pathogenic Species of Sporothrix. Fungal Biol. Rev. 2017, 31, 50–59. [Google Scholar] [CrossRef]
  26. Almeida-Paes, R.; Figueiredo-Carvalho, M.H.G.; Brito-Santos, F.; Almeida-Silva, F.; Oliveira, M.M.E.; Zancopé-Oliveira, R.M. Melanins Protect Sporothrix brasiliensis and Sporothrix schenckii from the Antifungal Effects of Terbinafine. PLoS ONE 2016, 11, e0152796. [Google Scholar] [CrossRef] [PubMed]
  27. Almeida-Paes, R.; Frases, S.; Araújo, G.D.S.; De Oliveira, M.M.E.; Gerfen, G.J.; Nosanchuk, J.D.; Zancopé-Oliveira, R.M. Biosynthesis and Functions of a Melanoid Pigment Produced by Species of the Sporothrix Complex in the Presence of l-Tyrosine. Appl. Environ. Microbiol. 2012, 78, 8623–8630. [Google Scholar] [CrossRef] [PubMed]
  28. Hatinguais, R.; Leaves, I.; Brown, G.D.; Brown, A.J.P.; Brock, M.; Peres Da Silva, R. CRISPR-Based Tools for Targeted Genetic Manipulation in Pathogenic Sporothrix Species. Microbiol. Spectr. 2023, 11, e05078-22. [Google Scholar] [CrossRef]
  29. Romero-Martinez, R.; Wheeler, M.; Guerrero-Plata, A.; Rico, G.; Torres-Guerrero, H. Biosynthesis and Functions of Melanin in Sporothrix schenckii. Infect. Immun. 2000, 68, 3696–3703. [Google Scholar] [CrossRef]
  30. Guan, M.; Yao, L.; Zhen, Y.; Song, Y.; Cui, Y.; Li, S. Melanin of Sporothrix globosa Affects the Function of THP-1 Macrophages and Modulates the Expression of TLR2 and TLR4. Microb. Pathog. 2021, 159, 105158. [Google Scholar] [CrossRef] [PubMed]
  31. Rodrigues, M.L.; Janbon, G.; O’Connell, R.J.; Chu, T.-T.-H.; May, R.C.; Jin, H.; Reis, F.C.G.; Alves, L.R.; Puccia, R.; Fill, T.P.; et al. Characterizing Extracellular Vesicles of Human Fungal Pathogens. Nat. Microbiol. 2025, 10, 825–835. [Google Scholar] [CrossRef] [PubMed]
  32. Rodrigues, M.L.; Nimrichter, L.; Oliveira, D.L.; Frases, S.; Miranda, K.; Zaragoza, O.; Alvarez, M.; Nakouzi, A.; Feldmesser, M.; Casadevall, A. Vesicular Polysaccharide Export in Cryptococcus neoformans Is a Eukaryotic Solution to the Problem of Fungal Trans-Cell Wall Transport. Eukaryot. Cell 2007, 6, 48–59. [Google Scholar] [CrossRef]
  33. Campos, R.M.S.; Jannuzzi, G.P.; Ikeda, M.A.K.; De Almeida, S.R.; Ferreira, K.S. Extracellular Vesicles from Sporothrix brasiliensis Yeast Cells Increases Fungicidal Activity in Macrophages. Mycopathologia 2021, 186, 807–818. [Google Scholar] [CrossRef] [PubMed]
  34. Ikeda, M.A.K.; De Almeida, J.R.F.; Jannuzzi, G.P.; Cronemberger-Andrade, A.; Torrecilhas, A.C.T.; Moretti, N.S.; Da Cunha, J.P.C.; De Almeida, S.R.; Ferreira, K.S. Extracellular Vesicles from Sporothrix brasiliensis Are an Important Virulence Factor That Induce an Increase in Fungal Burden in Experimental Sporotrichosis. Front. Microbiol. 2018, 9, 2286. [Google Scholar] [CrossRef]
  35. Zhang, Y.; Hagen, F.; Stielow, B.; Rodrigues, A.M.; Samerpitak, K.; Zhou, X.; Feng, P.; Yang, L.; Chen, M.; Deng, S.; et al. Phylogeography and Evolutionary Patterns in Sporothrix Spanning More than 14 000 Human and Animal Case Reports. Pers—Int. Mycol. J. 2015, 35, 1–20. [Google Scholar] [CrossRef]
  36. Huang, M.; Ma, Z.; Zhou, X. Comparative Genomic Data Provide New Insight on the Evolution of Pathogenicity in Sporothrix Species. Front. Microbiol. 2020, 11, 565439. [Google Scholar] [CrossRef]
  37. D’Alessandro, E.; Giosa, D.; Huang, L.; Zhang, J.; Gao, W.; Brankovics, B.; Oliveira, M.M.E.; Scordino, F.; Lo Passo, C.; Criseo, G.; et al. Draft Genome Sequence of the Dimorphic Fungus Sporothrix pallida, a Nonpathogenic Species Belonging to Sporothrix, a Genus Containing Agents of Human and Feline Sporotrichosis. Genome Announc. 2016, 4, e00184-16. [Google Scholar] [CrossRef]
  38. Huang, L.; Gao, W.; Giosa, D.; Criseo, G.; Zhang, J.; He, T.; Huang, X.; Sun, J.; Sun, Y.; Huang, J.; et al. Whole-Genome Sequencing and in Silico Analysis of Two Strains of Sporothrix globosa. Genome Biol. Evol. 2016, 8, 3292–3296. [Google Scholar] [CrossRef] [PubMed]
  39. Cuomo, C.A.; Rodriguez-Del Valle, N.; Perez-Sanchez, L.; Abouelleil, A.; Goldberg, J.; Young, S.; Zeng, Q.; Birren, B.W. Genome Sequence of the Pathogenic Fungus Sporothrix schenckii (ATCC 58251). Genome Announc. 2014, 2, e00446-14. [Google Scholar] [CrossRef]
  40. Teixeira, M.M.; De Almeida, L.G.; Kubitschek-Barreira, P.; Alves, F.L.; Kioshima, É.S.; Abadio, A.K.; Fernandes, L.; Derengowski, L.S.; Ferreira, K.S.; Souza, R.C.; et al. Comparative Genomics of the Major Fungal Agents of Human and Animal Sporotrichosis: Sporothrix schenckii and Sporothrix brasiliensis. BMC Genom. 2014, 15, 943. [Google Scholar] [CrossRef]
  41. Torres-Guerrero, H. Ploidy Study in Sporothrix schenkii. Fungal Genet. Biol. 1999, 27, 49–54. [Google Scholar] [CrossRef] [PubMed]
  42. Ferreira, B.H.; Ramírez-Prado, J.H.; Neves, G.W.P.; Torrado, E.; Sampaio, P.; Felipe, M.S.S.; Vasconcelos, A.T.; Goldman, G.H.; Carvalho, A.; Cunha, C.; et al. Ploidy Determination in the Pathogenic Fungus Sporothrix spp. Front. Microbiol. 2019, 10, 284. [Google Scholar] [CrossRef]
  43. Tavares, M.; Sousa-Filho, J.C.; Machado, I.A.; Gonçales, R.A.; Antunes, D.; Mendes-Frias, A.; Silvestre, R.; Carvalho, A.; Torrado, E.; Cunha, C.; et al. Development of a Versatile Toolbox for Genetic Manipulation of Sporothrix brasiliensis. Microbiol. Spectr. 2023, 11, e04564-22. [Google Scholar] [CrossRef] [PubMed]
  44. Rodrigues, A.M.; Gonçalves, S.S.; De Carvalho, J.A.; Borba-Santos, L.P.; Rozental, S.; Camargo, Z.P.D. Current Progress on Epidemiology, Diagnosis, and Treatment of Sporotrichosis and Their Future Trends. J. Fungi 2022, 8, 776. [Google Scholar] [CrossRef] [PubMed]
  45. Bose, J.L. Chemical and UV Mutagenesis. In The Genetic Manipulation of Staphylococci; Bose, J.L., Ed.; Methods in Molecular Biology; Springer: New York, NY, USA, 2014; Volume 1373, pp. 111–115. ISBN 978-1-4939-3157-6. [Google Scholar]
  46. Torres-Guerrero, H.; Arenas-López, G. UV Irradiation Induced High Frequency of Colonial Variants with Altered Morphology in Sporothrix schenckii. Med. Mycol. 1998, 36, 81–87. [Google Scholar] [CrossRef]
  47. Torres Guerrero, H.; Arenas-López, G.; Sabanero, M.; Bieler-Antolín, A.I.; Vélez, L.; Trejo, A. Phenotypic Characterization of the Morphological Mutant UVM9 of Sporothrix schenckii. Rev. Latinoam. Microbiol. 2008, 50, 5–12. [Google Scholar]
  48. Tachibana, T.; Matsuyama, T.; Ito, M.; Mitsuyama, M. Sporothrix schenckii Thermo-Intolerant Mutants Losing Fatal Visceral Infectivity but Retaining High Cutaneous Infectivity. Med. Mycol. 2001, 39, 295–298. [Google Scholar] [CrossRef]
  49. Morris-Jones, R.; Youngchim, S.; Gomez, B.L.; Aisen, P.; Hay, R.J.; Nosanchuk, J.D.; Casadevall, A.; Hamilton, A.J. Synthesis of Melanin-like Pigments by Sporothrix schenckii in Vitro and during Mammalian Infection. Infect. Immun. 2003, 71, 4026–4033. [Google Scholar] [CrossRef]
  50. Song, Y.; Yao, L.; Zhen, Y.; Cui, Y.; Zhong, S.; Liu, Y.; Li, S. Sporothrix globosa Melanin Inhibits Antigen presentation by Macrophages and Enhances Deep Organ Dissemination. Braz. J. Microbiol. 2021, 52, 19–31. [Google Scholar] [CrossRef]
  51. Fincham, J.R. Transformation in Fungi. Microbiol. Rev. 1989, 53, 148–170. [Google Scholar] [CrossRef]
  52. Zhang, Y.; Li, G.; He, D.; Yu, B.; Yokoyama, K.; Wang, L. Efficient Insertional Mutagenesis System for the Dimorphic Pathogenic Fungus Sporothrix schenckii Using Agrobacterium tumefaciens. J. Microbiol. Methods 2011, 84, 418–422. [Google Scholar] [CrossRef] [PubMed]
  53. Turgeon, B.G.; Condon, B.; Liu, J.; Zhang, N. Protoplast Transformation of Filamentous Fungi. In Molecular and Cell Biology Methods for Fungi; Sharon, A., Ed.; Methods in Molecular Biology; Humana Press: Totowa, NJ, USA, 2010; Volume 638, pp. 3–19. ISBN 978-1-60761-610-8. [Google Scholar]
  54. Lozoya-Pérez, N.E.; Casas-Flores, S.; Martínez-Álvarez, J.A.; López-Ramírez, L.A.; Lopes-Bezerra, L.M.; Franco, B.; Mora-Montes, H.M. Generation of Sporothrix schenckii Mutants Expressing the Green Fluorescent Protein Suitable for the Study of Host-Fungus Interactions. Fungal Biol. 2018, 122, 1023–1030. [Google Scholar] [CrossRef]
  55. Bundock, P.; Den Dulk-Ras, A.; Beijersbergen, A.; Hooykaas, P.J. Trans-Kingdom T-DNA Transfer from Agrobacterium tumefaciens to Saccharomyces cerevisiae. EMBO J. 1995, 14, 3206–3214. [Google Scholar] [CrossRef] [PubMed]
  56. Idnurm, A.; Bailey, A.M.; Cairns, T.C.; Elliott, C.E.; Foster, G.D.; Ianiri, G.; Jeon, J. A Silver Bullet in a Golden Age of Functional Genomics: The Impact of Agrobacterium-Mediated Transformation of Fungi. Fungal Biol. Biotechnol. 2017, 4, 6. [Google Scholar] [CrossRef]
  57. Nguyen, Q.B.; Kadotani, N.; Kasahara, S.; Tosa, Y.; Mayama, S.; Nakayashiki, H. Systematic Functional Analysis of Calcium-signalling Proteins in the Genome of the Rice-blast Fungus, Magnaporthe oryzae, Using a High-throughput RNA-silencing System. Mol. Microbiol. 2008, 68, 1348–1365. [Google Scholar] [CrossRef] [PubMed]
  58. Zhang, Z.; Hou, B.; Wu, Y.; Wang, Y.; Liu, X.; Han, S. Two-component Histidine Kinase DRK1 Is Required for Pathogenesis in Sporothrix schenckii. Mol. Med. Report. 2018, 17, 721–728. [Google Scholar] [CrossRef]
  59. Hou, B.; Zhang, Z.; Zheng, F.; Liu, X. Molecular Cloning, Characterization and Differential Expression of DRK1 in Sporothrix schenckii. Int. J. Mol. Med. 2013, 31, 99–104. [Google Scholar] [CrossRef]
  60. Lozoya-Pérez, N.E.; Casas-Flores, S.; De Almeida, J.F.; Martínez-Álvarez, J.A.; López-Ramírez, L.A.; Pereira Jannuzzi, G.; Trujillo-Esquivel, E.; Estrada-Mata, E.; Almeida, S.R.; Franco, B.; et al. Silencing of OCH1 Unveils the Role of Sporothrix schenckii N-Linked Glycans during the Host-Fungus Interaction. Infect. Drug Resist. 2018, 12, 67–85. [Google Scholar] [CrossRef]
  61. Nakayashiki, H.; Hanada, S.; Quoc, N.B.; Kadotani, N.; Tosa, Y.; Mayama, S. RNA Silencing as a Tool for Exploring Gene Function in Ascomycete Fungi. Fungal Genet. Biol. 2005, 42, 275–283. [Google Scholar] [CrossRef]
  62. Padró-Villegas, L.; Gómez-Gaviria, M.; Martínez-Duncker, I.; López-Ramírez, L.A.; Martínez-Álvarez, J.A.; Niño-Vega, G.A.; Mora-Montes, H.M. Sporothrix brasiliensis Gp70 Is a Cell Wall Protein Required for Adhesion, Proper Interaction with Innate Immune Cells, and Virulence. Cell Surf. 2025, 13, 100139. [Google Scholar] [CrossRef]
  63. Anzalone, A.V.; Koblan, L.W.; Liu, D.R. Genome Editing with CRISPR–Cas Nucleases, Base Editors, Transposases and Prime Editors. Nat. Biotechnol. 2020, 38, 824–844. [Google Scholar] [CrossRef]
  64. DiCarlo, J.E.; Norville, J.E.; Mali, P.; Rios, X.; Aach, J.; Church, G.M. Genome Engineering in Saccharomyces cerevisiae Using CRISPR-Cas Systems. Nucleic Acids Res. 2013, 41, 4336–4343. [Google Scholar] [CrossRef]
  65. Morio, F.; Lombardi, L.; Butler, G. The CRISPR Toolbox in Medical Mycology: State of the Art and Perspectives. PLoS Pathog. 2020, 16, e1008201. [Google Scholar] [CrossRef] [PubMed]
  66. Da Silva Ferreira, M.E.; Kress, M.R.V.Z.; Savoldi, M.; Goldman, M.H.S.; Härtl, A.; Heinekamp, T.; Brakhage, A.A.; Goldman, G.H. The akuBKU80 Mutant Deficient for Nonhomologous End Joining Is a Powerful Tool for Analyzing Pathogenicity in Aspergillus fumigatus. Eukaryot. Cell 2006, 5, 207–211. [Google Scholar] [CrossRef]
  67. Lopes-Bezerra, L.M.; Lozoya-Perez, N.E.; Lopez-Ramirez, L.A.; Martinez-Alvarez, J.A.; Teixeira, M.M.; Felipe, M.S.S.; Flores-Carreon, A.; Mora-Montes, H.M. Functional Characterization of Sporothrix schenckii Glycosidases Involved in the N-Linked Glycosylation Pathway. Med. Mycol. 2015, 53, 60–68. [Google Scholar] [CrossRef] [PubMed]
  68. López-Ramírez, L.A.; Hernández, N.V.; Lozoya-Pérez, N.E.; Lopes-Bezerra, L.M.; Mora-Montes, H.M. Functional Characterization of the Sporothrix schenckii Ktr4 and Ktr5, Mannosyltransferases Involved in the N-Linked Glycosylation Pathway. Res. Microbiol. 2018, 169, 188–197. [Google Scholar] [CrossRef]
  69. Robledo-Ortiz, C.I.; Flores-Carreón, A.; Hernández-Cervantes, A.; Álvarez-Vargas, A.; Lee, K.K.; Díaz-Jiménez, D.F.; Munro, C.A.; Cano-Canchola, C.; Mora-Montes, H.M. Isolation and Functional Characterization of Sporothrix schenckii ROT2, the Encoding Gene for the Endoplasmic Reticulum Glucosidase II. Fungal Biol. 2012, 116, 910–918. [Google Scholar] [CrossRef]
  70. Sánchez-López, J.F.; González-Ibarra, J.; Álvarez-Vargas, A.; Milewski, S.; Villagómez-Castro, J.C.; Cano-Canchola, C.; López-Romero, E. Isolation of the GFA1 Gene Encoding Glucosamine-6-Phosphate Synthase of Sporothrix schenckii and Its Expression in Saccharomyces cerevisiae. Protein Expr. Purif. 2015, 110, 57–64. [Google Scholar] [CrossRef] [PubMed]
  71. Wensing, L.; Shapiro, R.S. Design and Generation of a CRISPR Interference System for Genetic Repression and Essential Gene Analysis in the Fungal Pathogen Candida albicans. In Essential Genes and Genomes; Zhang, R., Ed.; Methods in Molecular Biology; Springer: New York, NY, USA, 2022; Volume 2377, pp. 69–88. ISBN 978-1-0716-1719-9. [Google Scholar]
Jof 12 00061 g001
Figure 1. Schematic overview of transformation methods used in Sporothrix species. (A) Polyethylene glycol (PEG)-mediated protoplast transformation (PMT) begins with the collection of hyphae from young cultures, followed by enzymatic digestion of the cell wall to release hyphal protoplasts. Intact protoplasts are then separated by filtration. For transformation, the desired DNA is mixed with calcium ions and PEG, which facilitate the uptake of exogenous genetic material. Protoplast regeneration is typically performed overnight at 25 °C, allowing cell wall reformation and recovery prior to selection. Transformed cells are subsequently plated onto selective media to distinguish successful transformants from non-transformed cells. Notably, filamentous fungi show higher transformation efficiency when protoplasts are derived from actively growing mycelium, making PMT a robust and reliable method for stable genetic modification. (B) Agrobacterium tumefaciens-mediated transformation (ATMT) is a widely used method for introducing foreign DNA into fungal genomes. It begins with the construction of a binary vector carrying the genes of interest, which is introduced into A. tumefaciens, usually via electroporation or chemical transformation. The bacterium is then co-cultivated with fungal yeast cells under conditions that promote T-DNA transfer. After co-cultivation, fungal cells are transferred to a selective medium containing appropriate antibiotics to eliminate Agrobacterium and identify fungal transformants.
Figure 1. Schematic overview of transformation methods used in Sporothrix species. (A) Polyethylene glycol (PEG)-mediated protoplast transformation (PMT) begins with the collection of hyphae from young cultures, followed by enzymatic digestion of the cell wall to release hyphal protoplasts. Intact protoplasts are then separated by filtration. For transformation, the desired DNA is mixed with calcium ions and PEG, which facilitate the uptake of exogenous genetic material. Protoplast regeneration is typically performed overnight at 25 °C, allowing cell wall reformation and recovery prior to selection. Transformed cells are subsequently plated onto selective media to distinguish successful transformants from non-transformed cells. Notably, filamentous fungi show higher transformation efficiency when protoplasts are derived from actively growing mycelium, making PMT a robust and reliable method for stable genetic modification. (B) Agrobacterium tumefaciens-mediated transformation (ATMT) is a widely used method for introducing foreign DNA into fungal genomes. It begins with the construction of a binary vector carrying the genes of interest, which is introduced into A. tumefaciens, usually via electroporation or chemical transformation. The bacterium is then co-cultivated with fungal yeast cells under conditions that promote T-DNA transfer. After co-cultivation, fungal cells are transferred to a selective medium containing appropriate antibiotics to eliminate Agrobacterium and identify fungal transformants.
Jof 12 00061 g001
Table 1. Comparative overview of genetic manipulation tools applied to Sporothrix species (key references are described in the text section).
Table 1. Comparative overview of genetic manipulation tools applied to Sporothrix species (key references are described in the text section).
Genetic ToolMechanismApplicationsStrengthsLimitations
Random mutagenesis (UV or chemical)Induces genome-wide mutations via UV light or mutagenic agents (e.g., N-methyl-N′-nitro-N-nitrosoguanidine (MNNG), nitrous acid)Analysis of thermotolerance, morphology, melanin biosynthesis, virulence attenuationTechnically simple; suitable for gain- and loss-of-function screeningLow reproducibility; genotype–phenotype link often unclear; laborious mutant
characterization
Protoplast-mediated transformation (PMT)Cell wall enzymatic digestion generates protoplasts for DNA uptake via Polyethylene glycol (PEG)/CaCl2 transformationIntroduction of plasmids, resistance markers, and CRISPR/Cas9 componentsApplicable to yeast and mycelial forms; compatible with ribonucleoprotein deliveryLow transformation efficiency: species-specific optimization required
Agrobacterium tumefaciens-mediated transformation (ATMT)T-DNA transfer from engineered A. tumefaciens into fungal genome during co-cultivationStable genomic integration; gene silencing via RNAi; green fluorescent protein (GFP) expressionNo protoplasts required, high efficiency in
hyphae and yeast cells		Integration sites are random; relies on bacterial–fungal compatibility
RNA interference (RNAi)Expression of hairpin RNA triggers post-transcriptional gene silencing via the Dicer/RISC complexFunctional analysis of virulence genes (GP70, OCH1, DRK1, ROT2)Enables partial knockdown; useful for essential genes; no genomic editing requiredVariable silencing efficiency; off-target effects; transformation-dependent
CRISPR/Cas9 gene editingCas9/sgRNA complex introduces targeted Double-Strand Break; repaired by non-homologous end-joining (NHEJ) or homologous recombination with donor DNATargeted gene deletion (pks1); use of Δku80 strains to enhance homologous recombinationPrecise genome editing; improved efficiency in recombination-deficient strainsDependent on protoplast transformation; early-stage adoption in Sporothrix spp.
Heterologous expressionCloning and expression of Sporothrix genes in model organisms (e.g., S. cerevisiae, C. albicans, Escherichia coli)Functional complementation; characterization of glycosylation enzymes, adhesins (e.g., ROT2, GFA1, Gp70, Pap1)Circumvents low transformation rates in native host; enables protein-level studiesMay lack post-translational modifications of native host; partial functional conservation
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.

Share and Cite

MDPI and ACS Style

Barros, M.; Tavares, M.; Silvestre, R.; Peres da Silva, R.; Rodrigues, F. Genetic Manipulation in Sporothrix Species: Molecular Tools, Challenges, and Applications. J. Fungi 2026, 12, 61. https://doi.org/10.3390/jof12010061

AMA Style

Barros M, Tavares M, Silvestre R, Peres da Silva R, Rodrigues F. Genetic Manipulation in Sporothrix Species: Molecular Tools, Challenges, and Applications. Journal of Fungi. 2026; 12(1):61. https://doi.org/10.3390/jof12010061

Chicago/Turabian Style

Barros, Mafalda, Matheus Tavares, Ricardo Silvestre, Roberta Peres da Silva, and Fernando Rodrigues. 2026. "Genetic Manipulation in Sporothrix Species: Molecular Tools, Challenges, and Applications" Journal of Fungi 12, no. 1: 61. https://doi.org/10.3390/jof12010061

APA Style

Barros, M., Tavares, M., Silvestre, R., Peres da Silva, R., & Rodrigues, F. (2026). Genetic Manipulation in Sporothrix Species: Molecular Tools, Challenges, and Applications. Journal of Fungi, 12(1), 61. https://doi.org/10.3390/jof12010061

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop